http://www.Nortonrosefulbright.comDescription© Copyright Norton Rose Fulbright 2013. All rights reserved.SaturdaySunday0123456789101113141517181920212223http://www.Nortonrosefulbright.com/common/images/logo_reverse.gifhttp://www.Nortonrosefulbright.com The 2013 Chambers Global Guide recognized 28 Fulbright lawyers as leading individuals and ranked the firm among the best law firms in the world in 37 se...Fri, 14 Jun 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/news/93078/fulbright-ranks-high-in-2013-chambers-global-guidehttp://www.nortonrosefulbright.com/news/93078/fulbright-ranks-high-in-2013-chambers-global-guidenrNewsOn May 1, 2013, the United States Trade Representative (“USTR”) released its annual IP report for 2013. Canada has been placed on the “Watch List" for 2013 due...Fri, 03 May 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/79960/pharma-in-brief-canada-ustr-slams-canada-over-the-treatment-of-pharmaceutical-patentshttp://www.nortonrosefulbright.com/knowledge/publications/79960/pharma-in-brief-canada-ustr-slams-canada-over-the-treatment-of-pharmaceutical-patentsnrPublicationOn April 26, 2013, Health Canada published a notice to inform clinical trial sponsors that information about clinical trials will be published.Tue, 30 Apr 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/79827/pharma-in-brief-canada-health-canada-authorizes-publication-of-clinical-trial-informationhttp://www.nortonrosefulbright.com/knowledge/publications/79827/pharma-in-brief-canada-health-canada-authorizes-publication-of-clinical-trial-informationnrPublicationLeading international legal practice Norton Rose has today announced 33 partner promotions globally including, in South Africa, six promotions to director.Wed, 24 Apr 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/news/79649/norton-rose-announces-33-global-promotions-ahead-of-us-combinationhttp://www.nortonrosefulbright.com/news/79649/norton-rose-announces-33-global-promotions-ahead-of-us-combinationnrNewsAstraZeneca Canada Inc. and AstraZeneca AB (“AstraZeneca”) brought an application pursuant to section 6 of the Patented Medicines (Notice of Compliance)...Thu, 28 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/77666/pharma-in-brief-canada-patent-for-esomeprazole-tablets-found-not-to-be-obvioushttp://www.nortonrosefulbright.com/knowledge/publications/77666/pharma-in-brief-canada-patent-for-esomeprazole-tablets-found-not-to-be-obviousnrPublication Fulbright was recognized as the leading trademark prosecution law firm of the South in Managing Intellectual Property's 2013 North America Awards se...Tue, 26 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/news/93082/fulbrights-trademark-prosecution-group-is-given-top-honorshttp://www.nortonrosefulbright.com/news/93082/fulbrights-trademark-prosecution-group-is-given-top-honorsnrNewsNovartis Pharmaceuticals Canada Inc. (“Novartis”) brought an application pursuant to s. 6 of the Patented Medicines (Notice of Compliance) Regulations for an...Fri, 22 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/77402/pharma-in-brief-canada-federal-court-issues-prohibition-order-in-respect-of-zoledronatehttp://www.nortonrosefulbright.com/knowledge/publications/77402/pharma-in-brief-canada-federal-court-issues-prohibition-order-in-respect-of-zoledronatenrPublicationTax has rarely been away from the headlines over the last few months. The Chancellor has faced repeated calls to clamp down on perceived tax avoidance, while at the Thu, 21 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/77205/uk-budget-2013http://www.nortonrosefulbright.com/knowledge/publications/77205/uk-budget-2013nrPublication Who Owns Global IP: Securing IP Ownership Rights Around the World Your client generates intellectual property domestically and perhaps in differen...Thu, 21 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/94270/acc-houston-intellectual-property-practice-grouphttp://www.nortonrosefulbright.com/knowledge/publications/94270/acc-houston-intellectual-property-practice-groupnrPublication In a landmark ruling on March 19th, the Supreme Court held in Kirtsaeng v. John Wiley & Sons, Inc., No. 11-697, that the "first sale" doct... Thu, 21 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/94626/supreme-court-holds-first-sale-doctrine-applies-to-grey-market-goods-resale-of-copyrighted-items-made-overseas-not-copyright-infringementhttp://www.nortonrosefulbright.com/knowledge/publications/94626/supreme-court-holds-first-sale-doctrine-applies-to-grey-market-goods-resale-of-copyrighted-items-made-overseas-not-copyright-infringementnrPublicationAstraZeneca Canada Inc. and AstraZeneca UK Limited (“AstraZeneca”) brought an application pursuant to section 6 of the Patented Medicines (Notice of Compliance)...Wed, 20 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/77262/pharma-in-brief-canada-federal-court-dismisses-prohibition-application-for-quetiapine-tabletshttp://www.nortonrosefulbright.com/knowledge/publications/77262/pharma-in-brief-canada-federal-court-dismisses-prohibition-application-for-quetiapine-tabletsnrPublication Who Owns Global IP: Securing IP Ownership Rights Around the World Your client generates intellectual property domestically and perhaps in differen...Wed, 20 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/93884/acc-houston-intellectual-property-practice-group-and-fulbright-luncheon-mccormick-schmickshttp://www.nortonrosefulbright.com/knowledge/publications/93884/acc-houston-intellectual-property-practice-group-and-fulbright-luncheon-mccormick-schmicksnrPublicationApotex Inc. (“Apotex”) brought an action for impeachment seeking a declaration that Lundbeck’s Canadian Patent No. 1,339,452 (the “’452 Patent”) is invalid.Mon, 18 Mar 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/77167/pharma-in-brief-canada-federal-court-upholds-validity-of-patent-for-escitalopram-cipralexhttp://www.nortonrosefulbright.com/knowledge/publications/77167/pharma-in-brief-canada-federal-court-upholds-validity-of-patent-for-escitalopram-cipralexnrPublicationTeva Canada Limited (“Teva”) and Apotex Inc. (“Apotex”) wish to sell generic versions of GLEEVEC®, a highly effective drug for the treatment of chronic myeloid...Tue, 26 Feb 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/75752/pharma-in-brief-canada-federal-court-upholds-validity-of-gleevec-patenthttp://www.nortonrosefulbright.com/knowledge/publications/75752/pharma-in-brief-canada-federal-court-upholds-validity-of-gleevec-patentnrPublicationThis was an appeal from a decision of the Federal Court granting Celgene Inc.’s (“Celgene”) application for judicial review and quashing a decision of the...Thu, 21 Feb 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/75600/pharma-in-brief-canada-federal-court-of-appeal-reverses-lower-court-decision-and-holds-that-thalomid-is-not-an-innovative-drughttp://www.nortonrosefulbright.com/knowledge/publications/75600/pharma-in-brief-canada-federal-court-of-appeal-reverses-lower-court-decision-and-holds-that-thalomid-is-not-an-innovative-drugnrPublicationFarah Mukaddam has written an article on the copyright dispute between online news publishers and news aggregators.Wed, 20 Feb 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/news/77143/e-commerce-law-policy-online-news-aggregation-services-the-disputehttp://www.nortonrosefulbright.com/news/77143/e-commerce-law-policy-online-news-aggregation-services-the-disputenrNewsLa dernière étude du cabinet d’avocats d’affaires international Norton Rose révèle une évolution sensible de la géographie mondiale dans les secteurs des technologieTue, 19 Feb 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/news/77171/lamerique-du-nord-repasse-en-tete-des-marches-les-plus-importants-dans-les-secteurs-des-technologies-des-medias-et-des-telecommunications-alors-que-linde-reculehttp://www.nortonrosefulbright.com/news/77171/lamerique-du-nord-repasse-en-tete-des-marches-les-plus-importants-dans-les-secteurs-des-technologies-des-medias-et-des-telecommunications-alors-que-linde-reculenrNews Fulbright has promoted seven senior associates and one senior counsel from key practice areas to join the firm's global partnership. Amber ...Thu, 31 Jan 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/news/93048/fulbright-names-eight-new-partnershttp://www.nortonrosefulbright.com/news/93048/fulbright-names-eight-new-partnersnrNewsEli Lilly Canada Inc. (“Lilly”) brought an application under the Patented Medicines (Notice of Compliance) Regulations (the “NOC Regulations”) for an Order...Mon, 28 Jan 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/74727/pharma-in-brief-canada-federal-court-confirms-that-where-noa-is-withdrawn-pmnoc-application-for-a-prohibition-order-is-moothttp://www.nortonrosefulbright.com/knowledge/publications/74727/pharma-in-brief-canada-federal-court-confirms-that-where-noa-is-withdrawn-pmnoc-application-for-a-prohibition-order-is-mootnrPublicationThis was an appeal from the decision of the Federal Court which had dismissed Takeda’s application for judicial review of the Minister’s refusal to list Takeda’s...Wed, 23 Jan 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/74623/pharma-in-brief-canada-federal-court-of-appeal-confirms-that-an-enantiomer-of-a-previously-approved-medicinal-ingredient-is-not-an-innovative-drughttp://www.nortonrosefulbright.com/knowledge/publications/74623/pharma-in-brief-canada-federal-court-of-appeal-confirms-that-an-enantiomer-of-a-previously-approved-medicinal-ingredient-is-not-an-innovative-drugnrPublicationThis is the first proceeding under the Patented Medicine (Notice of Compliance Regulations) (“NOC Regulations”) brought by Apotex Inc. Tue, 22 Jan 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/74566/pharma-in-brief-canada-ontario-superior-court-affirms-that-section-8-damages-do-not-include-disgorgement-of-innovators-profitshttp://www.nortonrosefulbright.com/knowledge/publications/74566/pharma-in-brief-canada-ontario-superior-court-affirms-that-section-8-damages-do-not-include-disgorgement-of-innovators-profitsnrPublication The 2012 edition of New York's Top Rated Lawyers recognized 31 Fulbright lawyers in 15 practice areas. The list is compiled by LexisNexis Mart...Tue, 22 Jan 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/news/93040/31-fulbright-lawyers-listed-as-new-yorks-top-rated-lawyershttp://www.nortonrosefulbright.com/news/93040/31-fulbright-lawyers-listed-as-new-yorks-top-rated-lawyersnrNewsThe Quebec government recently announced, as part of its budget, the intended abolishment of the rule known as “BAP-15.”Fri, 11 Jan 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/knowledge/publications/74229/pharma-in-brief-canada-changes-in-quebec-pharmaceutical-reimbursement-policyhttp://www.nortonrosefulbright.com/knowledge/publications/74229/pharma-in-brief-canada-changes-in-quebec-pharmaceutical-reimbursement-policynrPublicationDans le cadre du discours du budget, le gouvernement du Québec a récemment fait part de son intention d’abolir la règle des 15 ans, en vigueur depuis 1994.Fri, 11 Jan 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/centre-du-savoir/publications/74283/pharma-en-bref-canada-modification-a-la-politique-de-remboursement-des-medicaments-du-quebechttp://www.nortonrosefulbright.com/centre-du-savoir/publications/74283/pharma-en-bref-canada-modification-a-la-politique-de-remboursement-des-medicaments-du-quebecnrPublicationJeremy Tan comments on the PDPA broad objectives.Wed, 09 Jan 2013 00:00:00 GMThttp://www.nortonrosefulbright.com/news/74266/thomson-reuters-singapore-becomes-latest-country-in-asia-to-introduce-personal-data-privacy-lawhttp://www.nortonrosefulbright.com/news/74266/thomson-reuters-singapore-becomes-latest-country-in-asia-to-introduce-personal-data-privacy-lawnrNews